The uterine sarcomas form a group of malignant tumors that arises from the smooth muscle or connective tissue of the uterus. They can be difficult to detect, as symptoms are common to other uterine conditions and no specific screening test has been developed. This presents an issue for treatment, as the cancer spreads quickly.
Uterine sarcoma is rare and mostly occurs in post-menopausal women. The most common type, leiomyosarcoma, is twice as common in Black women as it is in white women. Uterine sarcoma condition is most commonly treated by radical hysterectomy. If cancer has spread beyond the uterus, radiation, chemotherapy, and hormonal therapy may be used.
If detected in its early stages, survival rates for uterine sarcoma are 66% after 5 years. If cancer has spread beyond the uterus, the survival rate declines to approximately 13-34%.[1]